| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |